Nektar to team with Bayer on inhaled antibiotic
Nektar Therapeutics, co-marketer of the inhaled insulin Exubera, has inked a deal to jointly develop an inhaled antibiotic to treat pneumonia with German drugmaker Bayer.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.